In Vitro corneal permeation of diclofenac from oil drops

被引:14
作者
Ahuja, Munish
Sharma, Surendra Kumar
Majumdar, Dipak Kanti
机构
[1] Univ Delhi, Delhi Inst Pharmaceut Sci & Res, Formerly Coll Pharm, New Delhi 110017, India
[2] Guru Jambheshwar Univ Sci & Technol, Dept Pharmaceut Sci, Hisar 125001, Haryana, India
来源
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN | 2007年 / 127卷 / 10期
关键词
diclofenac; sesame oil; benzyl alcohol; partition; Papp;
D O I
10.1248/yakushi.127.1739
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In vitro transcorneal permeation of diclofenac from oil drops was studied using freshly excised goat cornea. The maximum apparent corneal permeability coefficient (Papp) was obtained with 0.2% (w/v) diclofenac drops in sesame oil followed by safflower oil, while formulation in castor oil provided minimal Papp. The addition of benzyl alcohol, a preservative, in oil drops, increased the Papp value of diclofenac. Partition experiments indicated increased partitioning of diclofenac in the aqueous phase in the presence of benzyl alcohol, and the same could be responsible for the benzyl alcohol-induced increase in Papp. The solubility of diclofenac was higher in castor, arachis, and sunflower oil. But drug permeation from 0.5-1.0% (w/v) diclofenac drops in castor oil or 0.5% (w/v) drops in arachis /sunflower oil was less than that observed with 0.2% (w/v) drops in sesame oil. Thus diclofenac 0.2% (w/v) drops in sesame oil containing 0.5 % (v/v) benzyl alcohol provides maximum Papp. The formulation increased corneal hydration indicating corneal damage. Since corneal hydration is less than 83% the damage appears to be reversible. The saturation solubility of diclofenac in sesame oil at 4 degrees C is 0.33% (w/v). Hence diclofenac 0.2% (w/v) solution in sesame oil will not precipitate at 4 degrees C and therefore the chances of crystallization of diclofenac from the formulation due to climatic change leading to physical instability appear to be remote.
引用
收藏
页码:1739 / 1745
页数:7
相关论文
共 21 条
[1]   Effect of formulation factors on in vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea [J].
Ahuja, Munish ;
Dhake, Avinash Shridhar ;
Majumdar, Dipak Kanti .
YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2006, 126 (12) :1369-1375
[2]   COMPARATIVE-STUDY OF AQUEOUS AND OILY PILOCARPINE IN THE PRODUCTION OF OCULAR HYPOTENSION [J].
BHOJWANI, SC ;
JONES, DK .
BRITISH JOURNAL OF OPHTHALMOLOGY, 1981, 65 (08) :530-532
[3]  
COOPER CA, 1980, ARCH OPHTHALMOL-CHIC, V98, P1102
[4]   PGE2 synthesis by corneal endothelial cells:: Effect of glucocorticoids and NSAIDs [J].
García-Cabanes, C ;
Palmero, M ;
Bellot, JL ;
Orts, A .
OPHTHALMIC RESEARCH, 1999, 31 (01) :42-46
[5]   The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication [J].
Gordon, YJ ;
Araullo-Cruz, T ;
Romanowski, EG .
ARCHIVES OF OPHTHALMOLOGY, 1998, 116 (07) :900-905
[6]  
Haynes RC Jr, 1990, PHARMACOL BASIS THER, P1456
[7]  
HECHT G, 1990, MODERN PHARM, V40, P539
[8]   TOPICAL NONSTEROIDAL AGENTS AND CORNEAL WOUND-HEALING [J].
HERSH, PS ;
RICE, BA ;
BAER, JC ;
WELLS, PA ;
LYNCH, SE ;
MCGUIGAN, LJB ;
FOSTER, CS .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (04) :577-583
[9]   INHIBITION OF BLOOD-AQUEOUS HUMOR BARRIER BREAKDOWN WITH DICLOFENAC - A FLUOROPHOTOMETRIC STUDY [J].
KRAFF, MC ;
SANDERS, DR ;
MCGUIGAN, L ;
RAANAN, MG .
ARCHIVES OF OPHTHALMOLOGY, 1990, 108 (03) :380-383
[10]  
Longer MA, 1990, REMINGTONS PHARM SCI, P1687